Impact BioMedical to Begin Efficacy Testing of Pan-Coronavirus Vaccine Under New Wholly Owned Subsidiary Innate Immune, Inc.
- 2020年10月04日 14:27:00
- テクノロジー
- JCN Newswire
"Highly pathogenic human coronaviruses are continuously emerging and remain a major threat to human health,"stated Daryl Thompson, Impact BioLife's Director of Scientific Initiatives and founder of advanced research company GRDG Sciences, LLC ("GRDG"). Impact BioLife is a wholly owned subsidiary of Impact BioMedical. "Our pan-coronavirus vaccine is designed to allow us to not only protect against COVID-19, which is likely here to stay, but also allow for us to quickly respond to any outbreaks of a virus of this type in the future."
Coronaviruses are a large family of viruses and are common throughout the world. There are currently seven known human coronaviruses that can make people sick. Common human coronaviruses, including types 229E, NL63, OC43, and HKU1, usually cause mild to moderate upper-respiratory tract illnesses, while MERS-CoV, SARS-CoV, and now SARS-CoV2 can cause more severe pulmonary diseases.
"COVID-19 has already cost more than one million lives and continues to disrupt the $133 trillion global economy,"commented Jason Grady, COO of DSS. "A successful pan-coronavirus vaccine could save countless lives while lessening or even preventing the types of disruptions we have seen this year that have impacted nearly everyone on the planet."
Innate Immune's orally delivered pan-coronavirus vaccine has a well demonstrated safety profile and is designed to quickly be scaled for global distribution, ease of manufacturing, and high degree of stability. Innate Immune has gathered a globally recognized team of virologists to complete the research necessary to bring this vaccine to market.
"The need for a solution to COVID-19 and potential future human coronaviruses is clear. We believe this vaccine can provide that solution while remaining economically affordable, ensuring availability across the globe"stated Chan Heng Fai, Chairman of DSS.
GRDG's Chief Scientific Advisor Dr. Roscoe M. Moore, Jr., the former United States Assistant Surgeon General and former Epidemic Intelligence Service Officer at Centers for Disease Control and Prevention or CDC commented, "This pan-coronavirus vaccine is designed to boost a human's innate ability to fight viruses such as SARS-CoV2 by activating all phases of the human immune system. If successful, it could allow us to prevent further deaths and global economic disruptions from coronaviruses."
GRDG is a specialized research team that focuses on developing solutions for biodefense under the guidelines of the Project BioShield Act, Event 201, and Potomac Institute for Policy Studies.
GRDG performs rapid analysis and research by using advanced algorithms and the most complete databases in the world. The team operates in a lean and efficient manner and when necessary utilizes the top contract research organizations to deliver solid results that are robust and accurate.
About Impact BioMedical, Inc.
Impact BioMedical, Inc. ("Impact BioMedical") is a wholly owned subsidiary of DSS. Impact BioMedical strives to leverage its scientific know-how and intellectual property rights to provide solutions that have been plaguing the biomedical field for decades. By tapping into the scientific expertise of GRDG Sciences, LLC, Impact BioMedical pledges to undertake a concerted effort in the R&D, drug discovery and development for the prevention, inhibition, and treatment of neurological, oncological and immuno related diseases. For more information on Impact BioMedical visit http://impbio.com/.
About Document Security Systems, Inc.
DSS is a multinational company operating businesses focused on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets. Its business model is based on a distribution sharing system in which shareholders will receive shares in its subsidiaries as DSS strategically spins them out into IPOs. Its historic business revolves around counterfeit deterrent and authentication technologies, smart packaging, and consumer product engagement. DSS is led by its Chairman and largest shareholder, Mr. Fai Chan, a highly successful global business veteran of more than 40 years specializing in corporate transformation while managing risk. He has successfully restructured more than 35 corporations with a combined value of $25 billion. For more information on DSS visit http://www.dsssecure.com.
Investor Contact:
Dave Gentry, CEO
RedChip Companies Inc.
407-491-4498
Dave@redchip.com
Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com
プロ野球公式チア出身の葵くみ、初DVDで妖艶なシーンも 意味深タイトル「そこは想像にお任せ」
「グラジャパ!AWARD2023」グランプリの菊地姫奈が映画「みーんな、宇宙人。」出演
【阪神】登録抹消の青柳晃洋「結果を出すしかないと思う」31日ロッテ戦4回3失点の背信投球
ダルビッシュ、左股関節痛で今季2度目IL入り マーリンズ戦で左太もも裏に張り訴え3回で降板
松本潤「独立して初仕事」新会社設立を発表「まずは舞台の稽古、頑張っていこうと」インスタ更新
絢香、15年ぶりフルオーケストラで熱唱「森の中で癒やしのマイナスイオンが振って来るようです」
プロ注目の早大・吉納翼が早慶戦2発で完全優勝王手 報道陣と西武の憧れ先輩にいろいろおねだり
【阪神】伊藤将司、7日西武戦で先発濃厚 2軍戦2試合で防御率0・69と結果 青柳が2軍調整
【日本ハム】田宮裕涼、打率リーグトップ「感じが良かった」新ルーティンが生き山田コーチに感謝
時間がない!どうする?【心理テスト】意思決定スタイルを診断!
何があった!?「エアコン」が想定外の壊れ具合!投稿者に話を聞いた
柏原崇(45)現在を調べてみた結果、相変わらずかっこよすぎた!
大原櫻子、ガーシー暴露後初のSNS投稿に賛否の声「イメージ最悪になった」
「暴露します」松本人志飲み会参加セクシー女優「衝撃作」発売「言えなくてずっと溜めてた」
玉置浩二の妻、青田典子(53)の現在がとんでもない事になっていると話題に
漫才師の今くるよさん死去 膵がんのため
ユーチューバーもこう氏、元彼女・成海瑠奈について赤裸々告白
浜崎あゆみ、子供の写真公開に疑いの声止まず「よそのお宅の子供?」
大谷翔平被弾投手が悪態ついて退場処分!次打者フリーマンと対戦中に判定巡り塁審と口論
金正恩の妹・金与正関連のネタ投稿がTwitterで大量に出回る
何があった!?「エアコン」が想定外の壊れ具合!投稿者に話を聞いた
柏原崇(45)現在を調べてみた結果、相変わらずかっこよすぎた!
玉置浩二の妻、青田典子(53)の現在がとんでもない事になっていると話題に
ユーチューバーもこう氏、元彼女・成海瑠奈について赤裸々告白
元めちゃイケメンバーの三中元克(32)現在は何をしているのか調べてみた!
TikTokを賑わす「フエラムネごめんなサイダー味」がセブンイレブンで再販!じゅるるマスカットも買うなら今!
小倉優子、不自然な“二重ライン”にネット騒然「やっぱり整形?」
ガーシーが綾野剛のLINE公開でネット騒然「ショック」「すごいエンタメ」
岡本夏生(56)、1600日ぶりにブログを更新した現在が衝撃
大原櫻子、ガーシー暴露後初のSNS投稿に賛否の声「イメージ最悪になった」
プロ野球公式チア出身の葵くみ、初DVDで妖艶なシーンも 意味深タイトル「そこは想像にお任せ」
「グラジャパ!AWARD2023」グランプリの菊地姫奈が映画「みーんな、宇宙人。」出演
【阪神】登録抹消の青柳晃洋「結果を出すしかないと思う」31日ロッテ戦4回3失点の背信投球
ダルビッシュ、左股関節痛で今季2度目IL入り マーリンズ戦で左太もも裏に張り訴え3回で降板
松本潤「独立して初仕事」新会社設立を発表「まずは舞台の稽古、頑張っていこうと」インスタ更新
絢香、15年ぶりフルオーケストラで熱唱「森の中で癒やしのマイナスイオンが振って来るようです」
【日本ハム】田宮裕涼、打率リーグトップ「感じが良かった」新ルーティンが生き山田コーチに感謝
プロ注目の早大・吉納翼が早慶戦2発で完全優勝王手 報道陣と西武の憧れ先輩にいろいろおねだり
【阪神】伊藤将司、7日西武戦で先発濃厚 2軍戦2試合で防御率0・69と結果 青柳が2軍調整
時間がない!どうする?【心理テスト】意思決定スタイルを診断!